Fogchain Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

.......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... .......... Justin Crowe, founder and CEO of Parting Stone in Santa Fe, pictured in 2019. The company take human and pet remains and turns them into solidified remains. (Eddie Moore/Albuquerque Journal) ALBUQUERQUE, N.M. — Santa Fe-based Parting Stone’s novel technology to turn cremated ashes into beautiful, solidified remains is rapidly gaining ground in the “deathcare” industry. The company, which la...

Share: NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N. M., May 04, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (formerly, FogChain Corp.) (the "Company") is pleased to announce the closing of its previously announced reverse takeover transaction (the "Transaction") with Avisa Pharma Inc. ("Avisa"). In accordance with the merger agreement and plan of reorganization dated February 1, 2021 (the "Merger Agreement"), which superseded and replaced the previously announced Letter of Intent dated January 12, 2021, the Transaction w...

FogChain Announces Shares For Debt Settlement FogChain Corp. announces that the Company intends to settle a total of $85,000 of debt owed to an administrative services provider of the Company, through the issuance of an aggregate of 1,545,454 common shares of the Company at a deemed price of $0.055 per Debt Share . All the Debt Shares issued in connection with the Debt Settlement are subject to a statutory hold period of four months plus a day from the date …  FogChain Corp. (CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the ” Company ” or ” FogChain “), announces that the Company inten...

 (CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the " Company" or " FogChain") is pleased to announce, further to its news release dated January 13, 2021, the Company has entered into a merger agreement and plan of reorganization (the " Definitive Agreement") with Avisa Pharma Inc. (" Avisa") and FogChain USA Inc., a wholly-owned subsidiary of FogChain, dated February 1, 2021, in respect of a statutory merger under the Delaware General Corporation Law pursuant to which the Company has agreed to acquire all of the issued and outstanding shares in the capital of Avisa (the " Avisa Shares"), a private...